Auriga

Ten Analyst Calls That Made You 60-Plus Percent in 2012

UPDATE: Auriga Raises Target to $19 on Worthington Industries

UPDATE: Auriga Raises PT to $135 on TransDigm

UPDATE: Auriga Raises Target to $19 on Worthington Industries

UPDATE: Auriga Raises PT to $135 on TransDigm

Auriga: FDA Approves Peginesatide

Auriga Increases Steve Madden's EPS Estimates

Auriga: FDA Approves Peginesatide

Auriga Increases Steve Madden's EPS Estimates

UPDATE: Auriga Cuts PT to $88 on Weight Watchers International

UPDATE: Auriga Raises PT to $22 on AAR Corporation

Auriga Recent News

UPDATE: Auriga Raises PT to $128 on Nike

UPDATE: Auriga Raises PT to $8 on PMC-Sierra

UPDATE: Auriga Downgrades Anthera Pharmaceuticals

Auriga: Affymax Earnings Still Not a Major Driver

Auriga: Unemployment and Economy Improvement at Healthcare Services

UPDATE: Auriga Lowers PT to $21 on Medifast

UPDATE: Auriga Raises PT to $86 on Lululemon Athletica

UPDATE: Auriga Raises PT to $65 on DSW

UPDATE: Auriga Upgrades Salix Pharmaceuticals to Buy

UPDATE: Auriga Raises PT to $57 on JAZZ Pharmaceuticals

UPDATE: Auriga Raises PT to $51 on Universal Health Services

Auriga Reiterates Buy, $9 Target on eResearch

UPDATE: Auriga Raises PT to $13 on EXACT Sciences

UPDATE: Auriga Increases Price Target on Herbalife to $66

UPDATE: Auriga Raises Price Target on the Medicines Company to $25

UPDATE: Auriga Lowers Yingli Green Energy's PT

Auriga Updates Trina Solar's Estimates

UPDATE: Auriga Raises Canadian Solar's PT

UPDATE: Auriga Raises Suntech Power's PT

UPDATE: Auriga Lowers Community Health Systems' PT

Auriga Increases Estimates on HEICO

Auriga: Chiquita Reports Lower 4Q Revenue, Improved EPS

Auriga Reiterates Buy, $12 PT on Chiquita Brands